Boston Scientific Corporation (LON:0HOY)
97.39
+0.94 (0.97%)
At close: Oct 9, 2025
Boston Scientific Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Net Income | 2,498 | 1,846 | 1,592 | 698 | 1,041 | -82 | Upgrade |
Depreciation & Amortization | 1,315 | 1,269 | 1,196 | 1,136 | 1,093 | 1,123 | Upgrade |
Stock-Based Compensation | 286 | 266 | 233 | 220 | 194 | 170 | Upgrade |
Other Adjustments | -183 | 515 | 253 | 478 | -106 | 320 | Upgrade |
Change in Receivables | -262 | -351 | -238 | -220 | -279 | 335 | Upgrade |
Changes in Inventories | -53 | -228 | -660 | -321 | -346 | -65 | Upgrade |
Changes in Accounts Payable | 468 | 243 | 118 | -255 | 408 | -28 | Upgrade |
Changes in Other Operating Activities | -108 | -126 | 10 | -209 | -134 | -265 | Upgrade |
Operating Cash Flow | 4,285 | 3,435 | 2,503 | 1,526 | 1,870 | 1,508 | Upgrade |
Operating Cash Flow Growth | 62.80% | 37.23% | 64.02% | -18.40% | 24.01% | -17.87% | Upgrade |
Capital Expenditures | -800 | -790 | -711 | -588 | -554 | -376 | Upgrade |
Sale of Property, Plant & Equipment | - | 3 | 4 | 12 | 14 | 12 | Upgrade |
Purchases of Investments | -251 | -280 | -89 | -24 | - | - | Upgrade |
Proceeds from Sale of Investments | - | - | - | - | 279 | -146 | Upgrade |
Payments for Business Acquisitions | -5,793 | -4,640 | -1,811 | -1,542 | -2,258 | -3 | Upgrade |
Proceeds from Business Divestments | - | - | - | 5 | 826 | 15 | Upgrade |
Other Investing Activities | - | 20 | 32 | 126 | 97 | 87 | Upgrade |
Investing Cash Flow | -6,757 | -5,687 | -2,574 | -2,011 | -1,597 | -411 | Upgrade |
Short-Term Debt Issued | - | 24 | - | - | - | 4,161 | Upgrade |
Short-Term Debt Repaid | - | -504 | - | -250 | - | -4,869 | Upgrade |
Net Short-Term Debt Issued (Repaid) | - | -480 | - | -250 | - | -708 | Upgrade |
Long-Term Debt Issued | - | 2,145 | - | 3,270 | - | 1,683 | Upgrade |
Long-Term Debt Repaid | - | - | - | -3,184 | - | -1,260 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | 2,145 | - | 86 | - | 423 | Upgrade |
Issuance of Common Stock | 41 | 230 | 182 | 136 | 110 | 1,086 | Upgrade |
Repurchase of Common Stock | -130 | -87 | -56 | -53 | -50 | -594 | Upgrade |
Net Common Stock Issued (Repurchased) | -89 | 143 | 126 | 83 | 60 | 492 | Upgrade |
Issuance of Preferred Stock | - | - | - | - | - | 975 | Upgrade |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | - | 975 | Upgrade |
Preferred Share Dividends Paid | - | - | -28 | -55 | -55 | -28 | Upgrade |
Other Financing Activities | - | 5 | -93 | -411 | -100 | -860 | Upgrade |
Financing Cash Flow | 114 | 1,814 | 5 | -548 | -95 | 293 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 38 | -11 | -4 | -9 | -6 | -2 | Upgrade |
Net Cash Flow | -2,321 | -450 | -70 | -1,042 | 173 | 1,388 | Upgrade |
Beginning Cash & Cash Equivalents | 3,062 | 1,055 | 1,126 | 2,168 | 1,995 | 607 | Upgrade |
Ending Cash & Cash Equivalents | 741 | 606 | 1,055 | 1,126 | 2,168 | 1,995 | Upgrade |
Free Cash Flow | 3,485 | 2,645 | 1,792 | 938 | 1,316 | 1,132 | Upgrade |
Free Cash Flow Growth | 31.76% | 47.60% | 91.05% | -28.72% | 16.25% | -17.67% | Upgrade |
FCF Margin | 18.84% | 15.79% | 12.58% | 7.40% | 11.07% | 11.42% | Upgrade |
Free Cash Flow Per Share | 2.34 | 1.78 | 1.22 | 0.65 | 0.92 | 0.80 | Upgrade |
Levered Free Cash Flow | 3,327 | 3,886 | 1,523 | 241 | 1,452 | -11 | Upgrade |
Unlevered Free Cash Flow | 3,443 | 2,474 | 1,832 | 771.77 | 1,626 | 306.97 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.